Hardy Kornfeld MD
Critical Care Medicine, Pleural Disease
Professor, Medicine, University Massachusetts Medical School
Join to View Full Profile
55 Lake Ave NWorcester, MA 01655
Phone+1 774-443-2781
Fax+1 774-442-3999
Are you Dr. Kornfeld?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Hardy Kornfeld, MD is a pulmonologist in Worcester, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is a Professor at University Massachusetts Medical School.
Education & Training
- Boston University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1982 - 1986
- Boston University Medical CenterResidency, Internal Medicine, 1978 - 1980
- Boston University School of MedicineClass of 1978
Certifications & Licensure
- MA State Medical License 1982 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- Inflammatory profiles in sputum and blood of people with TB with and without HIV coinfection.Sara C Auld, Artur T L Queiroz, Mariana Araujo-Pereira, Pholo Maenetje, Nomsa Mofokeng
Tuberculosis. 2025-03-01 - Association of Altered Baseline Hematological Parameters with Adverse Tuberculosis Treatment Outcomes.Arul Nancy Pandiarajan, Nathella Pavan Kumar, Kadar Moideen, Kannan Thiruvengadam, Syed Hissar
Pathogens. 2025-02-04 - Factors Associated With Unfavorable Treatment Outcomes Among Persons With Pulmonary Tuberculosis: A Multicentric Prospective Cohort Study From India.Senbagavalli Prakash Babu, Komala Ezhumalai, Kalaivani Raghupathy, Meagan Karoly, Palanivel Chinnakali
Clinical Infectious Diseases. 2024-10-15
Grant Support
- A Biosafety Level 3 Laboratory for Viral PathogensUNIV OF MASSACHUSETTS MED SCH WORCESTER2024–2027
- A Biosafety Level 3 Laboratory for Viral PathogensUNIV OF MASSACHUSETTS MED SCH WORCESTER2024–2027
- A Biosafety Level 3 Laboratory for Viral PathogensUNIV OF MASSACHUSETTS MED SCH WORCESTER2024–2027
- A Biosafety Level 3 Laboratory for Viral PathogensUNIV OF MASSACHUSETTS MED SCH WORCESTER2024–2027
- A Biosafety Level 3 Laboratory for Viral PathogensUNIV OF MASSACHUSETTS MED SCH WORCESTER2024–2027
- Unleashing CD8+ T Cells for TB DefenseUNIV OF MASSACHUSETTS MED SCH WORCESTER2024–2026
- Unleashing CD8+ T Cells for TB DefenseUNIV OF MASSACHUSETTS MED SCH WORCESTER2024–2026
- Unleashing CD8+ T Cells for TB DefenseUNIV OF MASSACHUSETTS MED SCH WORCESTER2024–2026
- Unleashing CD8+ T Cells for TB DefenseUNIV OF MASSACHUSETTS MED SCH WORCESTER2024–2026
- Unleashing CD8+ T Cells for TB DefenseUNIV OF MASSACHUSETTS MED SCH WORCESTER2024–2026
- BSL3 Enhancements for RNA Virus Pandemic PreparednessUNIV OF MASSACHUSETTS MED SCH WORCESTER2022–2025
- Lung-Protective Mechanisms of Metformin in TBUNIV OF MASSACHUSETTS MED SCH WORCESTER2021–2025
- Sirtuins and Host Metabolism in TB Pathogenesis and TreatmentUNIV OF MASSACHUSETTS MED SCH WORCESTER2021–2025
- Trial of Metformin for TB/HIV Host-directed TherapyUNIV OF MASSACHUSETTS MED SCH WORCESTER2019–2025